EMEA-001988-PIP01-16-M01
Key facts
Invented name |
GHRYVELIN (previously Macimorelin Aeterna Zentaris)
|
Active substance |
Macimorelin
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/0076/2020
|
PIP number |
EMEA-001988-PIP01-16-M01
|
Pharmaceutical form(s) |
Granules for oral solution
|
Condition(s) / indication(s) |
Diagnosis of growth hormone deficiency
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Aeterna Zentaris GmbH
E-mail: macrilen@aezsinc.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|